Developing real-world digital biomarkers from wearable sensors in Alzheimer’s disease

Jen Blankenship, VivoSense Inc. Michael Busa, UMass Amherst. The aim of this project is to develop and validate algorithms to capture measures of real-world walking behavior in patients with Alzheimer’s disease (AD). This project will provide critical validation evidence to support regulatory decision making.

Continue ReadingDeveloping real-world digital biomarkers from wearable sensors in Alzheimer’s disease

Testing a vocal biomarker platform for remote detection and monitoring of cognitive impairment in the home environment

Erik Larsen, Sonde Health. Brad Dickerson, Massachusetts General Hospital. Bonnie Wong, Massachusetts General Hospital. This project enrolls 50 subjects, age 55 and above, to participate in a longitudinal pilot study examining the potential to monitor mental status as a way to detect potential declines in cognitive functioning through a voice analysis (vocal biomarker) platform implemented on an existing smartphone app. The focus of this study is on feasibility in naturalistic environments (home) vs. controlled laboratory setting.

Continue ReadingTesting a vocal biomarker platform for remote detection and monitoring of cognitive impairment in the home environment

Fall 2022 Pilot Grant Competition Launched

  • Post category:News

MassAITC is pleased to announce that the Fall 2022 pilot grant competition has now opened. An overview of the MassAITC pilot grant program is available at https://massaitc.org/grants. The request for proposals is available at https://massaitc.org/rfpf22/. An introductory webinar will be held in conjunction with the a2 Collective on July 14th at 3:00pm ET (click here to register). Round 1 project proposals are due August 15th, 2022 and can be submitted through the a2 Pilot Awards common application site. For key dates, details about the application process, and FAQs, click here.

Continue ReadingFall 2022 Pilot Grant Competition Launched